Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

NCT00038506 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: abacavir/lamivudine/zidovudine
DRUG: tenofovir

Sponsor

ViiV Healthcare